pc ¹öÀüÀ¸·Î À̵¿ Áß [½ÃÀ庸°í¼­]°¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, °Ë»ç Àå¼Òº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
°¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, °Ë»ç Àå¼Òº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Software), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2024 - 2030
»óÇ°ÄÚµå : 1511977
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 190 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,650,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,104,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 13,012,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è °¨¿°º´ ü¿ÜÁø´Ü ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È CAGR 2.4%¸¦ ±â·ÏÇϸç 2030³â±îÁö 280¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°áÇÙ, COVID-19¿Í °°Àº °¨¿°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ±â¼ú ¹ßÀüÀÌ ÇâÈÄ ¸î ³â µ¿¾È Á¦Ç° ¼ö¿ä¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ÙÁ¦³»¼º °¨¿°ÁõÀÇ Áõ°¡·Î ÀÎÇØ °¨¿°ÁõÀÇ Á¶±â Áø´ÜÀÌ °­È­µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â Microbial Drug Resistance Journal¿¡ µû¸£¸é ÁßÁõ SARS-CoV-2 ȯÀÚÀÇ MDR °¨¿° À¯º´·üÀº 14%-50%¿´½À´Ï´Ù.

°¨¿° Áø´Ü Àü Áø´Ü°ú Ç×»ýÁ¦ Ä¡·áÀÇ Áö¿¬À¸·Î ÀÎÇØ Ç×»ýÁ¦ ³»¼º±ÕÀÇ È®»êÀÌ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ¾÷°è ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÏ°í ÀÖ½À´Ï´Ù. ¾÷°è´Â ¼ÒºñÀÚÀÇ ¼ö¿ä¸¦ ÃæÁ·½ÃÅ°±â À§ÇØ ¼ö¸¹Àº Á¦Ç°À» Ãâ½ÃÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 5¿ù, BD´Â ¹Ì±¹¿¡¼­ °¨¿°¼º Áúȯ ÀÚµ¿ Áø´Ü Ç÷§ÆûÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº 1700°³ÀÇ °Ëü¸¦ ÀûÀçÇÒ ¼ö ÀÖÀ¸¸ç, °Ëü¸¦ ¼±º°ÇÒ ÇÊ¿ä°¡ ¾ø¾î ¿À·ù¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ °æÀï»çµéÀÌ Á¦°øÇÏ´Â Á¦Ç°Àº °æÀï»ç °£ÀÇ Àû´ëÀû °ü°è¸¦ °­È­Çϱâ À§ÇØ Àü·«ÀûÀ¸·Î °¡°ÝÀ» Ã¥Á¤ÇÏ°í ÀÖ½À´Ï´Ù.

±×·¯³ª ¹Î°¨µµ¿Í ½Å³äÀÇ Â÷ÀÌ·Î ÀÎÇØ ¼ÒºñÀÚ°¡ PoC °Ë»ç¿Í ½ÇÇè½Ç ±â¹Ý °Ë»ç Áß Çϳª¸¦ ¼±ÅÃÇØ¾ß ÇÏ´Â °æ¿ì, ±¸¸Å ÇൿÀÇ º¹À⼺ÀÌ ´«¿¡ ¶ç°Ô Áõ°¡ÇÕ´Ï´Ù. ¾÷°è´Â È£ÇÁ¸¸ ¶ó ·Î½´, ¾Ë·¹¸£, ¹ÙÀÌ¿À¸ÓƼ¸®¾ó, BD µîÀÌ °úÁ¡Àû ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ¾÷°è´Â °¡°Ý¿¡ ¹Î°¨Çϸç, ºñ¿ë È¿À²ÀûÀÌ°í È¿À²ÀûÀÎ Á¦Ç°À» »ý»êÇϱâ À§ÇØ ¾÷ü °£ °æÀïÀÌ Ä¡¿­ÇÏ°Ô Àü°³µÇ°í ÀÖ½À´Ï´Ù. »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ Å°Æ®ÀÇ Ãâ½Ã°¡ ¿¹»óµÊ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °æÀï»çµé °£ÀÇ Àû´ëÀû °ü°è´Â Áõ°¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. °æÀï»çµéÀº ½ÃÀå Á¡À¯À²À» ³ôÀ̱â À§ÇØ Á¦Ç° Ãâ½Ã ¹× ÀÎÁöµµ Çâ»ó ÇÁ·Î±×·¥ ½ÇÇà°ú °°Àº Áß¿äÇÑ Àü·«À» äÅÃÇÏ°í ÀÖ½À´Ï´Ù.

°¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå : ±â¼úº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå : °Ë»ç Àå¼Òº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °¨¿°Áõ ü¿ÜÁø´Ü ½ÃÀå : Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï »óȲ

ksm 24.07.18
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Infectious Disease In Vitro Diagnostics Market Growth & Trends:

The global infectious disease in vitro diagnostics market size is expected to reach USD 28.05 billion by 2030, registering a CAGR of 2.4% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.

The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.

However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMerieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.

Infectious Disease In Vitro Diagnostics Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Infectious Disease In Vitro Diagnostics Market Variables, Trends, & Scope

Chapter 4. Infectious Disease In Vitro Diagnostics Market: Product Estimates & Trend Analysis

Chapter 5. Infectious Disease In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

Chapter 6. Infectious Disease In Vitro Diagnostics Market: Application Estimates & Trend Analysis

Chapter 7. Infectious Disease In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

Chapter 8. Infectious Disease In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â